| Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
|---|---|---|---|---|---|---|
| 2016 | All-oral daclatasvir plus asunaprevir for chronic hepatitis C virus (HCV) genotype 1b infection: a sub-analysis in Asian patients from the HALLMARK DUAL study | JIA-HORNG KAO ; Lee Y.-J.; Heo J.; Ahn S.-H.; Lim Y.-S.; Peng C.-Y.; Chang T.-T.; Torbeyns A.; Hughes E.; Bhore R.; Noviello S. | Liver International | 22 | 25 | |
| 2014 | All-oral daclatasvir plus asunaprevir for hepatitis C virus genotype 1b: A multinational, phase 3, multicohort study | Manns M.; Pol S.; Jacobson I.M.; Marcellin P.; Gordon S.C.; Peng C.-Y.; Chang T.-T.; Everson G.T.; Heo J.; Gerken G.; Yoffe B.; Towner W.J.; Bourliere M.; Metivier S.; Chu C.-J.; Sievert W.; Bronowicki J.-P.; Thabut D.; Lee Y.-J.; JIA-HORNG KAO ; McPhee F.; Kopit J.; Mendez P.; Linaberry M.; Hughes E.; Noviello S. | The Lancet | 300 | 276 | |
| 2008 | Antifungal activity of essential oil and its constituents from Calocedrus macrolepis var. formosana Florin leaf against plant pathogenic fungi | Chang H.-T.; Cheng Y.-H.; Wu C.-L.; Chang S.-T.; Chang T.-T.; HUI-TING CHANG ; SHANG-TZEN CHANG | Bioresource Technology | 142 | 128 | |
| 2003 | Childhood Langerhans cell histiocytosis increased during El Ni?o 1997-98: A report from the Taiwan Pediatric Oncology Group | Chen R.-L.; Lin K.-S.; Chang W.-H.; Hsieh Y.-L.; Chen B.-W.; Jaing T.-H.; Yang C.-P.; Hung I.-J.; Peng C.-T.; Shu S.-G.; MENG-YAO LU ; Jou S.-T.; Lin K.-H.; Lin D.-T.; Lin M.-T.; Chen J.-S.; Liu H.-C.; Chen S.-H.; Liang D.-C.; Chiou S.-S.; Chang T.-T.; Sheen J.-M.; Hsiao C.-C.; Cheng S.-N.; Lin J.-C. | Acta Paediatrica Taiwanica | 10 | 0 | |
| 2005 | Comparison of a 6-month course peginterferon α-2b plus ribavirin and interferon α-2b plus ribavirin in treating Chinese patients with chronic hepatitis C in Taiwan | Lee S.-D.; Yu M.-L.; Cheng P.-N.; Lai M.-Y.; Chao Y.-C.; Hwang S.-J.; Chang W.-Y.; Chang T.-T.; Hsieh T.-Y.; CHUN-JEN LIU ; DING-SHINN CHEN | Journal of Viral Hepatitis | 78 | 70 | |
| 2005 | Comparison of recurrence after hepatic resection in patients with hepatitis B vs. hepatitis C-related small hepatocellular carcinoma in hepatitis B virus endemic area | Huang Y.-H.; Wu J.-C.; CHIEN-HUNG CHEN ; Chang T.-T.; Lee P.-C.; Chau G.-Y.; Lui W.-Y.; Chang F.-Y.; Lee S.-D. | Liver International | 64 | 63 | |
| 2007 | Cost-effectiveness of peginterferon alfa-2a compared to lamivudine treatment in patients with hepatitis B e antigen positive chronic hepatitis B in Taiwan | Sullivan S.D.; Veenstra D.L.; PEI-JER CHEN ; Chang T.-T.; Chuang W.-L.; Tsai C.; Patel K. | Journal of Gastroenterology and Hepatology (Australia) | 24 | 22 | |
| 2010 | Cross-cultural differences on work-to-family conflict and role satisfaction: A taiwanese-british comparison | Lu L.; Cooper C.L.; Kao S.-F.; Chang T.-T.; Allen T.D.; Lapierre L.M.; O'driscoll M.P.; Poelmans S.A.Y.; Sanchez J.I.; Spector P.E.; LUO LU | Human Resource Management | 93 | 80 | |
| 2009 | Cured meat, vegetables, and bean-curd foods in relation to childhood acute leukemia risk: A population based case-control study | CHEN-YU LIU ; Hsu Y.-H.; Wu M.-T.; Pan P.-C.; Ho C.-K.; Su L.; Xu X.; Li Y.; Christiani D.C.; Chang T.-T.; Lin S.-F.; Chiou S.-S.; Jang R.-C.; Hsiao H.-H.; Liu T.-C.; Lin P.-C.; Wong Y.-C.; Wu H.-B.; Lin S.-J.; Sun Y.-M.; Hsieh K.-S.; Chang Y.-H.; Wong Y.-C.; Wu H.-B.; Lin S.-J.; Sun Y.-M.; Hsieh K.-S.; Chang Y.-H. | BMC Cancer | 28 | 23 | |
| 2017 | Daclatasvir/asunaprevir/beclabuvir, all-oral, fixed-dose combination for patients with chronic hepatitis C virus genotype 1 | JIA-HORNG KAO ; Yu M.-L.; Peng C.-Y.; Heo J.; Chu C.-J.; Chang T.-T.; Lee Y.-J.; Hu T.-H.; Yoon K.T.; Paik S.W.; Lim Y.S.; Ahn S.H.; Isakov V.; McPhee F.; Hu W.; Scott Swenson E.; Yin P.D.; Treitel M. | Journal of Gastroenterology and Hepatology (Australia) | 16 | 12 | |
| 2006 | Do young hepatocellular carcinoma patients have worse prognosis? The paradox of age as a prognostic factor in the survival of hepatocellular carcinoma patients | CHIEN-HUNG CHEN ; Chang T.-T.; Cheng K.-S.; Su W.-W.; Yang S.-S.; Lin H.H.; Wu S.-S.; Lee C.-M.; Changchien C.-S.; Chen C.-J.; JIN-CHUAN SHEU ; DING-SHINN CHEN ; Lu S.-N. | Liver International | 62 | 56 | |
| 2013 | Effect of human leukocyte antigen class I and II alleles on hepatitis C viral load among chronic hepatitis C patients in Southern Taiwan | Tseng K.-C.; Tseng C.-W.; Hsieh Y.-H.; CHIN-KUO CHANG ; Lai N.-S.; Hung T.-H.; Chang T.-T. | Human Immunology | 3 | 3 | |
| 2018 | Efficacy of Ledipasvir and Sofosbuvir Treatment of HCV Infection in Patients Coinfected With HBV | CHUN-JEN LIU ; Chuang W.-L.; Sheen I.-S.; Wang H.-Y.; Chen C.-Y.; Tseng K.-C.; Chang T.-T.; Massetto B.; Yang J.C.; Yun C.; Knox S.J.; Osinusi A.; Camus G.; Jiang D.; Brainard D.M.; McHutchison J.G.; Hu T.-H.; Hsu Y.-C.; Lo G.-H.; Chu C.-J.; Chen J.-J.; Peng C.-Y.; Chien R.-N.; PEI-JER CHEN | Gastroenterology | 89 | 81 | |
| 2002 | Eight-year nationwide survival analysis in relatives of patients with hepatocellular carcinoma: Role of viral infection | Tai D.-I.; CHIEN-HUNG CHEN ; Chang T.-T.; Chen S.-C.; Liao L.-Y.; Kuo C.-H.; Chen Y.; Chen G.-H.; Yang S.-S.; Tang H.-S.; Lin H.H.; Lin D.-Y.; Lo S.K.; Du J.-M.; Lin K.-C.; Changchien C.-S.; Chang W.-Y.; JIN-CHUAN SHEU ; Liaw Y.-F.; DING-SHINN CHEN ; Sung J.-L. | Journal of Gastroenterology and Hepatology (Australia) | 25 | 21 | |
| 2020 | Fatty‐acid‐binding protein 4 as a novel contributor to mononuclear cell activation and endothelial cell dysfunction in atherosclerosis | YEN-WEN WU ; Chang T.-T.; Chang C.-C.; Chen J.-W. | International Journal of Molecular Sciences | 14 | 13 | |
| 2009 | Geographic variations of predominantly hepatitis C virus associated male hepatocellular carcinoma townships in Taiwan: Identification of potential high HCV endemic areas | Su W.-W.; CHIEN-HUNG CHEN ; Lin H.H.; Yang S.-S.; Chang T.-T.; Cheng K.-S.; Wu J.-C.; Wu S.-S.; Lee C.-M.; Changchien C.-S.; Chen C.-J.; JIN-CHUAN SHEU ; DING-SHINN CHEN ; Lu S.-N. | Hepatology International | 12 | 10 | |
| 2009 | HBV DNA level as an important determinant of E antigen seroconversion of chronic hepatitis B during Adefovir dipivoxil therapy | Tseng K.-C.; Cheng P.-N.; Wu I.-C.; CHIN-KUO CHANG ; Chou A.-L.; Liu W.-C.; Chang T.-T. | Hepato-Gastroenterology | 5 | 5 | |
| 2004 | Hepatitis B virus transmission and hepatocarcinogenesis: A 9 year retrospective cohort of 13 676 relatives with hepatocellular carcinoma | CHIEN-HUNG CHEN ; Chen Y.Y.; Chen G.-H.; Yang S.-S.; Tang H.-S.; Lin H.H.; Lin D.-Y.; Lo S.K.; Du J.-M.; Chang T.-T.; Chen S.-C.; Liao L.-Y.; Kuo C.-H.; Lin K.-C.; Tai D.-I.; Changchien C.-S.; Chang W.-Y.; JIN-CHUAN SHEU ; DING-SHINN CHEN ; Liaw Y.-F.; Sung J.-L. | Journal of Hepatology | 44 | 32 | |
| 2011 | Improved efficacy and tolerability of oral deferasirox by twice-daily dosing for patients with transfusion-dependent β-thalassemia | Chang H.-H, MENG-YAO LU ; Liao Y.-M.; Liao Y.-M.; YUNG-LI YANG ; Yang Y.-L.; Chiou S.-S.; SHIANN-TANG JOU ; Lin K.-H.; Chang T.-T.; Chang T.-T.; Chang T.-T. | Pediatric Blood and Cancer | 32 | 24 | |
| 2006 | Improved treatment results for childhood acute myeloid leukemia in Taiwan | Liang D.-C.; Chang T.-T.; Lin K.-H.; Lin D.-T.; MENG-YAO LU ; Chen S.-H.; Liu H.-C.; Lin M.-T.; Lee M.-T.; Shu S.-G.; Chang T.-K.; Chen J.-S.; Hsiao C.-C.; Hung I.-J.; Hsieh Y.-L.; Chen R.-L.; Cheng S.-N.; Chang W.-H.; Lee C.-H.; Lin K.-S. | Leukemia | 37 | 32 |
